Calculating Risk for Poor Outcomes After Transcatheter Aortic Valve Replacement
Abstract OBJECTIVE: To outline the tools available to help understand the risk of transcatheter aortic valve replacement (TAVR) and the gaps in […]
World's Largest Resource for Cardiovascular Perfusion
Abstract OBJECTIVE: To outline the tools available to help understand the risk of transcatheter aortic valve replacement (TAVR) and the gaps in […]
The present findings indicate that LVETc∕PAWP is a potential predictor of successful weaning from VA‐ECMO.
Prophylactic corticosteroids are often administered during cardiac surgery to attenuate the inflammatory response to cardiopulmonary bypass and surgical trauma; however, evidence that routine corticosteroid use can prevent major adverse events is lacking.